Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Ho Wah Genting Berhad Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Ho Wah Genting Berhad şirketinin toplam hissedar öz sermayesi MYR91.3M ve toplam borcu MYR22.9M olup, bu da borç-öz sermaye oranını 25.1% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla MYR168.3M ve MYR77.0M dir. Ho Wah Genting Berhad 'in FAVÖK'ü MYR6.1M faiz karşılama oranı 4.9 dur. Şirketin MYR17.6M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

25.1%

Borç/özkaynak oranı

RM 22.89m

Borç

Faiz karşılama oranı	4.9x
Nakit	RM 17.57m
Eşitlik	RM 91.29m
Toplam yükümlülükler	RM 76.97m
Toplam varlıklar	RM 168.26m

Son finansal sağlık güncellemeleri

Is Ho Wah Genting Berhad (KLSE:HWGB) A Risky Investment?

Jul 25

These 4 Measures Indicate That Ho Wah Genting Berhad (KLSE:HWGB) Is Using Debt Reasonably Well

May 22

Ho Wah Genting Berhad (KLSE:HWGB) Has A Somewhat Strained Balance Sheet

Dec 06

Here's Why Ho Wah Genting Berhad (KLSE:HWGB) Can Afford Some Debt

Jul 08

Recent updates

Is Ho Wah Genting Berhad (KLSE:HWGB) A Risky Investment?

Jul 25

Ho Wah Genting Berhad's (KLSE:HWGB) Shares Bounce 26% But Its Business Still Trails The Industry

Jun 18

These 4 Measures Indicate That Ho Wah Genting Berhad (KLSE:HWGB) Is Using Debt Reasonably Well

May 22

Ho Wah Genting Berhad (KLSE:HWGB) Has A Somewhat Strained Balance Sheet

Dec 06

Returns Are Gaining Momentum At Ho Wah Genting Berhad (KLSE:HWGB)

Oct 05

Here's Why Ho Wah Genting Berhad (KLSE:HWGB) Can Afford Some Debt

Jul 08

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: HWGB 'nin kısa vadeli varlıkları ( MYR127.9M ) kısa vadeli yükümlülüklerini ( MYR64.1M ) aşıyor.

Uzun Vadeli Yükümlülükler: HWGB şirketinin kısa vadeli varlıkları ( MYR127.9M ) uzun vadeli yükümlülüklerini ( MYR12.9M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: HWGB 'nin net borç/öz sermaye oranı ( 5.8% ) tatmin edici olarak değerlendirilmektedir.

Borcun Azaltılması: HWGB 'nin borç/öz sermaye oranı son 5 yılda 74.7% seviyesinden 25.1% seviyesine düştü.

Borç Kapsamı: HWGB 'nin borcu işletme nakit akışı ( 81.6% ) tarafından iyi bir şekilde karşılanmaktadır.

Faiz Kapsamı: HWGB 'in borcuna ilişkin faiz ödemeleri EBIT ( 4.9 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.

Ho Wah Genting Berhad Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Is Ho Wah Genting Berhad (KLSE:HWGB) A Risky Investment?

These 4 Measures Indicate That Ho Wah Genting Berhad (KLSE:HWGB) Is Using Debt Reasonably Well

Ho Wah Genting Berhad (KLSE:HWGB) Has A Somewhat Strained Balance Sheet

Here's Why Ho Wah Genting Berhad (KLSE:HWGB) Can Afford Some Debt

Recent updates

Second quarter 2024 earnings released: EPS: RM0.006 (vs RM0.036 loss in 2Q 2023)

Is Ho Wah Genting Berhad (KLSE:HWGB) A Risky Investment?

Ho Wah Genting Berhad Appoints Madam Lim Ean Chin as Independent and Non Executive Director

Ho Wah Genting Berhad's (KLSE:HWGB) Shares Bounce 26% But Its Business Still Trails The Industry

Ho Wah Genting Berhad (KLSE:HWGB) Is Experiencing Growth In Returns On Capital

First quarter 2024 earnings released: RM0.001 loss per share (vs RM0.036 loss in 1Q 2023)

Ho Wah Genting Berhad Announces the Resignation of Elaine Tan Ai Lin as Independent and Non Executive Chairman of Nomination and Remuneration Committee

Full year 2023 earnings released: EPS: RM0.007 (vs RM0.01 loss in FY 2022)

New major risk - Market cap size

New minor risk - Financial data availability

Ho Wah Genting Berhad (KLSE:HWGB) Is Experiencing Growth In Returns On Capital

New major risk - Market cap size

New minor risk - Shareholder dilution

Many Still Looking Away From Ho Wah Genting Berhad (KLSE:HWGB)

These 4 Measures Indicate That Ho Wah Genting Berhad (KLSE:HWGB) Is Using Debt Reasonably Well

Full year 2022 earnings released: RM0.003 loss per share (vs RM0.009 loss in FY 2021)

Second quarter 2023 earnings released: EPS: RM0.002 (vs RM0.007 loss in 2Q 2022)

Ho Wah Genting Berhad (KLSE:HWGB) Has A Somewhat Strained Balance Sheet

Returns Are Gaining Momentum At Ho Wah Genting Berhad (KLSE:HWGB)

Full year 2022 earnings released: RM0.009 loss per share (vs RM0.046 loss in FY 2021)

Ho Wah Genting Berhad, Annual General Meeting, Sep 28, 2022

Ho Wah Genting Berhad has completed a Follow-on Equity Offering in the amount of MYR 2.939792 million.

Here's Why Ho Wah Genting Berhad (KLSE:HWGB) Can Afford Some Debt

Ho Wah Genting Berhad Announces Appointment of Khalid Bin Ahmad Husni as Independent and Non Executive Member of Nomination and Remuneration Committee

Full year 2022 earnings released: RM0.009 loss per share (vs RM0.046 loss in FY 2021)

Ho Wah Genting Berhad Update on Phase 4 United States Food and Drug Administration Clinical Trial of Sars-Cov-2 Vaccine Study

Ho Wah Genting Berhad Appoints Kay Wong-Alafriz, as Advisor

New 90-day low: RM0.55

Full year 2020 earnings released: RM0.044 loss per share (vs RM0.019 loss in FY 2019)

Ho Wah Genting Berhad Appoints Law Phooi Wong as Advisor to the Board

Ho Wah Genting Berhad Announces Update on Phase 4 Clinical Trial of Sars-Cov-2 Vaccine Study

Ho Wah Genting Berhad Receives Product Registration Approval for Astramern Astra H Capsule from NPRA for A Period Commencing 14 January 2021 to 14 January 2026

Ho Wah Genting Berhad Enters into Memorandum of Understanding with Chongqing ISIA Bio-Technology Co., Ltd (ISIA) to Manufacture and Produce in Vitro Diagnostic Products

New 90-day low: RM0.59

Ho Wah Genting Berhad Provides Update on Phase 4 Clinical Trial of Sars-Cov-2 Vaccine Study

Ho Wah Genting Berhad Announces Benjamin Leong Wye Hoong as Independent and Non Executive Director

New 90-day high: RM0.89

Ho Wah Genting Berhad Provides Update on the Joint Venture Project with E-Mo Biology Inc

Third quarter 2020 earnings released: RM0.002 loss per share

Ho Wah Genting Berhad Enters into Memorandum of Understanding with GNOSIS LABORATORIES (M) SDN BHD

Ho Wah Genting Berhad Provides Update on the Joint Venture Project with E-Mo Biology Inc

Ho Wah Genting Berhad Announces Appointment as the Authorized Sale Agent/ Distributor for the Covid-19 related products from Wuhan Easy Diagnosis Biomedicine Co.,Ltd

Ho Wah Genting Berhad Announces Resignation of Mr. Bernard Lim Soon Chiang as Independent and Non Executive Member of Remuneration Committee

Ho Wah Genting Berhad Announces Redesignation of Mr. Kenny Yeoh Khi Khen from Independent and Non Executive Member of Risk Committee to Chairman of Risk Committee

First half earnings released

Dato Lim Ooi Hong, Lim Wee Kiat and Datuk Teo Tiew, Executive Directors of Ho Wah Genting Berhad completed the acquisition of remaining 70.24% stake in Ho Wah Genting Berhad (KLSE:HWGB).

New 90-day high - RM0.60

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin